Exacerbated vein graft arteriosclerosis in protein kinase Cdelta-null mice

M Leitges1, M Mayr, U Braun

  • 1Max Planck Institute for Experimental Endocrinology, Hannover, Germany.

Insights

Protein kinase C delta (PKCdelta) deficiency in smooth muscle cells (SMCs) worsens vein graft arteriosclerosis by reducing SMC death. PKCdelta is crucial for maintaining SMC homeostasis and normal vascular function.

Area of Science:

  • Vascular Biology
  • Cellular Signaling
  • Atherosclerosis Research

Background:

  • Smooth muscle cell (SMC) accumulation drives atherosclerosis, including vein bypass graft disease.
  • Protein kinase C (PKC) signaling pathways regulate SMC fate (proliferation, differentiation, apoptosis).

Purpose of the Study:

  • To investigate the role of PKCdelta in SMC behavior and vein graft arteriosclerosis development.

Main Methods:

  • Generated and utilized PKCdelta knockout (PKCdelta(-/-)) mice for vein bypass grafting experiments.
  • Compared arteriosclerosis severity, SMC accumulation, and SMC apoptosis in PKCdelta(-/-) and wild-type (PKCdelta(+/+)) grafts.
  • Assessed SMC resistance to apoptosis and related molecular pathways (caspase-3, PARP, cytochrome c) in vitro.

Main Results:

  • PKCdelta(-/-) vein grafts exhibited more severe arteriosclerosis with increased SMCs and decreased SMC death compared to wild-type grafts.
  • SMCs from PKCdelta(-/-) mice showed resistance to apoptosis induction, characterized by diminished caspase-3 activation and mitochondrial dysfunction.
  • PKCdelta deficiency did not affect SMC proliferation in vitro.

Conclusions:

  • PKCdelta plays a critical role in maintaining SMC homeostasis within the vessel wall.
  • Loss of PKCdelta function exacerbates vein graft arteriosclerosis by promoting SMC survival and impairing apoptotic responses.

Related Concept Videos